Shopping Cart
- Remove All
- Your shopping cart is currently empty
L-threo-PPMP is an inhibitor of GlcT, which is the UDP-Glc: Ceramide β1,1glucosyltransferase enzyme. It effectively inhibits glycosphingolipid biosynthesis, while also inducing apoptosis. These properties of L-threo-PPMP contribute to its notable anti-cancer activity.
Pack Size | Price | Availability | Quantity |
---|---|---|---|
5 mg | $970 | Backorder |
Description | L-threo-PPMP is an inhibitor of GlcT, which is the UDP-Glc: Ceramide β1,1glucosyltransferase enzyme. It effectively inhibits glycosphingolipid biosynthesis, while also inducing apoptosis. These properties of L-threo-PPMP contribute to its notable anti-cancer activity. |
In vitro | L-threo-PPMP, at concentrations ranging from 0.5 to 20 μM, initiates apoptosis in carcinoma cells (Colo-205; SKBR3) within 6 hours and causes DNA damage within 24 to 48 hours post-treatment[1]. Additionally, at dosages between 1 to 16 μM over 48 hours, it activates Caspase-3 in SKBR3 breast cancer cells[1]. |
Molecular Weight | 474.73 |
Formula | C29H50N2O3 |
Cas No. | 207278-87-3 |
Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice. |
Copyright © 2015-2024 TargetMol Chemicals Inc. All Rights Reserved.